Potassium Carbonate → 5-(1,4-Diazepan-1-yl)-2-pyridinyl phenyl sulfone methanesulfonic acid salt

HRID 23875

Reaktionsgleichung

[C:1]1([S:7]([C:10]2[CH:15]=[CH:14][C:13](Cl)=[CH:12][N:11]=2)(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C(=O)([O-])[O-:18].[K+].[K+].[NH:23]1[CH2:29][CH2:28][CH2:27][NH:26][CH2:25][CH2:24]1>CN(C=O)C>[CH3:10][S:7]([OH:8])(=[O:9])=[O:18].[C:1]1([S:7]([C:10]2[CH:15]=[CH:14][C:13]([N:23]3[CH2:29][CH2:28][CH2:27][NH:26][CH2:25][CH2:24]3)=[CH:12][N:11]=2)(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1

Komponenten

Reaktionsbedingungen

Temperatur: 85 °C

Versuchsvorschrift

To a mixture of 5-chloro-2-pyridinyl phenyl sulfone (2.0 g, 7.9 mmol) in DMF (50 mL) was added potassium carbonate (2.5 g, 18 mmol) and homopiperazine (1.7 g, 17 mmol). The mixture was heated at 85° C. for 72 h. The mixture then was removed from heat and partitioned between water and ethyl acetate. The layers were separated and the organic layer washed twice with water (2×100 ml). The organic layer was dried over anhydrous magnesium sulfate and concentrated. Column chromatography (silica gel, 75 mL) using 5% CH3OH in CH2Cl2 with 0.7% NH4OH and conversion to the methanesulfonate salt gave 0.182 g of the title compound; IR (drift) 1570, 1304, 1240, 1223, 1207, 1196, 1178, 1145, 1112, 1059, 1052, 785, 715, 688, 645 cm−1. 1H NMR (DMSO-d6) δ2.0, 3.1, 3.2, 3.38, 3.56, 3.78, 7.26, 7.64, 7.88, 8.21, 8.67.

Aufarbeitung

customThe mixture then was removed
temperaturefrom heat
custompartitioned between water and ethyl acetate
customThe layers were separated
washthe organic layer washed twice with water (2×100 ml)
dry with materialThe organic layer was dried over anhydrous magnesium sulfate
concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag: ord-57c79025038d40cb8650cc9c2598fcb7
Quelldatensatz: uspto-grants-2005_02
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US06855709B2

Verknüpfte Notizen

Wird geladen…